I'll respond to the developments there.
First of all, if you've got a citation for the patients in the veterans administration dying on wait-lists for particular medications, I'd appreciate seeing that. It would be nice to look at it.
On the issue with respect to accountability, we do want publicly accountable bodies that are making coverage decisions. They need to be accountable through fair and transparent processes. I think Canada actually is an exemplar on the world stage. I give a lot of credit to the Canadian Agency for Drugs and Technologies in Health and to the federal-provincial collaboration on the common drug review. It is a reasonably robust and reasonably transparent process that they have under way right now. A similar process, with some new elements to its mandate, could be conducted. Again, it's conducted by an agency that's at arm's length from political influence.
This would not be unique to Canada. Other countries around the world have similar infrastructure in place. Countries like Germany, Sweden, the Netherlands, Australia, New Zealand, the United Kingdom, all have agencies that are at some level arm's length from politicians. It's specifically to protect you from being lobbied by the manufacturers of a particular medicine that want their medicine on the formulary at a cost that isn't justified vis-à-vis other ways of improving the health of the population.